DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Macugen (Pegaptanib) - Cerebral Infarction - Suspected Cause - Side Effect Reports

 
 



Index of reports > Cases with Cerebral Infarction (4)

Below is the selection of side effect reports (a.k.a. adverse event reports) related to Macugen (Pegaptanib) where reactions include cerebral infarction. The selected reports were submitted to the FDA during the sample period of about a year.

Possible Macugen side effects in male

Reported by a physician from Japan on 2012-08-09

Patient: male

Reactions: Cerebral Infarction

Drug(s) suspected as cause:
Macugen

Other drugs received by patient: Levofloxacin



Possible Macugen side effects in male

Reported by a physician from Japan on 2012-07-19

Patient: male

Reactions: Cerebral Infarction

Drug(s) suspected as cause:
Macugen

Other drugs received by patient: Levofloxacin



Possible Macugen side effects in 82 year old male

Reported by a physician from Japan on 2011-11-28

Patient: 82 year old male

Reactions: Cerebral Infarction

Drug(s) suspected as cause:
Macugen
    Dosage: 0.3 mg into the left eye, intraocular
    Indication: Choroidal Neovascularisation
    Start date: 2010-05-25

Macugen
    Dosage: 0.3 mg into the left eye, intraocular
    Indication: AGE-Related Macular Degeneration
    Start date: 2010-05-25

Other drugs received by patient: Levofloxacin



Possible Macugen side effects in 90 year old male

Reported by a physician from Japan on 2011-11-16

Patient: 90 year old male, weighing 51.0 kg (112.2 pounds)

Reactions: Cerebral Infarction, Blood Pressure Systolic Increased

Adverse event resulted in: death

Drug(s) suspected as cause:
Macugen

Other drugs received by patient: Levofloxacin; Humalin (Insulin); Urief (Silodosin); Bromfenac Sodium (Bromfenac Sodium); Fulcaliq (Amino Acids Nos, Electrolytes Nos, Glucose, Vitamins Nos); Xylocaine

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017